Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

PharmaLundensis

0.20 SEK

-6.10 %

Less than 1K followers

PHAL

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for PharmaLundensis

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)1.310.810.910.710.450.610.25
Shares28.328.331.933.942.651.060.0
Market cap37.222.929.124.119.231.314.8
Enterprise value37.925.832.428.421.835.818.3
EV/S-------
EV/EBITDAneg.neg.neg.neg.neg.neg.neg.
EV/EBITneg.neg.neg.neg.neg.neg.neg.
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B6.077.789.1113.676.069.505.14
P/S-------
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio61.0 %38.5 %38.5 %20.1 %28.8 %32.8 %32.1 %
Gearing ratio32.7 %127.8 %130.7 %263.5 %163.0 %173.6 %164.5 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.